Development of a framework for minimum and optimal safety and quality standards for hemodialysis and peritoneal dialysis

      Substantial heterogeneity in practice patterns around the world has resulted in wide variations in the quality and type of dialysis care delivered. This is particularly so in countries without universal standards of care and governmental (or other organizational) oversight. Most high-income countries have developed such oversight based on documentation of adherence to standardized, evidence-based guidelines. Many low- and lower-middle-income countries have no or only limited organized oversight systems to ensure that care is safe and effective. The implementation and oversight of basic standards of care requires sufficient infrastructure and appropriate workforce and financial resources to support the basic levels of care and safety practices. It is important to understand how these standards then can be reasonably adapted and applied in low- and lower-middle-income countries.

      Keywords

      To read this article in full you will need to make a payment
      ISN Member Login
      ISN Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Prasad N.
        • Jha V.
        Hemodialysis in Asia.
        Kidney Dis. 2015; 1: 165-177
        • International Society of Peritoneal Dialysis
        ISPD guidelines.
        (Available at:)
        https://ispd.org/ispd-guidelines
        Date accessed: March 8, 2019
        • Szeto C.C.
        • Li P.K.T.
        • Johnson D.W.
        • et al.
        International Society for Peritoneal Dialysis (ISPD) catheter-related infection recommendations: 2017 update.
        Perit Dial Int. 2017; 37: 141-154
        • Brown E.A.
        • Bargman J.
        • van Biesen W.
        • et al.
        Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis: position paper for ISPD–update 2017.
        Perit Dial Int. 2017; 37: 362-374
        • Li P.K.T.
        • Szeto C.C.
        • Piraino B.
        • et al.
        ISPD peritonitis recommendations: 2016 update on prevention and treatment.
        Perit Dial Int. 2016; 36: 481-508
        • Wang A.Y.M.
        • Brimble K.S.
        • Brunier G.
        • et al.
        ISPD guidelines on assessment and management of various cardiovascular risk factors in chronic adult peritoneal dialysis patients.
        Perit Dial Int. 2015; 35: 379-387
        • Wang A.Y.M.
        • Brimble K.S.
        • Brunier G.
        • et al.
        ISPD guidelines on management of various cardiovascular complications in chronic adult peritoneal dialysis patients.
        Perit Dial Int. 2015; 35: 388-396
        • Boudville N.
        • Johnson D.W.
        • Zhao J.
        • et al.
        Regional variation in the treatment and prevention of peritoneal dialysis related infections in the peritoneal dialysis outcomes and practice patterns study.
        Nephrol Dial Transplant. 2019; 34: 2118-2126
        • Htay H.
        • Cho Y.
        • Pascoe E.M.
        • et al.
        Center effects and PD peritonitis outcomes: a national registry analysis.
        Am J Kidney Dis. 2018; 71: 814-821
        • Nadeau-Fredette A.C.
        • Johnson D.W.
        • Hawley C.M.
        • et al.
        Centre-specific factors associated with peritonitis risk - a multi-center registry analysis.
        Perit Dial Int. 2016; 36: 509-518
        • Htay H.
        • Cho Y.
        • Pascoe E.M.
        • et al.
        Multi-center registry analysis of center characteristics associated with technique failure in incident peritoneal dialysis patients.
        Clin J Am Soc Nephrol. 2017; 12: 1090-1099
        • Teerawattananon Y.
        • Luz A.
        • Pilasant S.
        • et al.
        How to meet the demand for good quality renal dialysis as part of universal health coverage in resource-limited settings?.
        Health Res Policy Syst. 2016; 14: 21
        • Fervers B.
        • Burgers J.S.
        • Voellinger R.
        • et al.
        Guideline adaptation: an approach to enhance efficiency in guideline development and improve utilisation.
        BMJ Qual Saf. 2011; 20: 228-236
        • Indian Society of Nephrology
        Guidelines for maintenance hemodialysis in India.
        (Available at:)
        http://www.imanhb.org/p
        Date accessed: May 4, 2018
        • Luyckx V.A.
        • Smyth B.
        • Harris D.C.H.
        • Pecoits-Filho R.
        Dialysis funding, eligibility, procurement, and protocols in low- and middle-income settings: results from the International Society of Nephrology collection survey.
        Kidney Int Suppl. 2020; 10: e10-e18
        • Liyanage T.
        • Ninomiya T.
        • Jha V.
        • et al.
        Worldwide access to treatment for end-stage kidney disease: a systematic review.
        Lancet. 2015; 385: 1975-1982
        • Jardine M.
        • Commons R.
        • de Zoysa J.R.
        • et al.
        Kidney Health Australia-Caring for Australasians with Renal Impairment guideline recommendations for infection control for haemodialysis units.
        Nephrology (Carlton). 2019; 24: 951-957
        • European Best Practices Guidelines Working Group
        European Best Practice Guidelines for haemodialysis (Part 1). Section IV. Dialysis fluid purity.
        Nephrol Dial Transplant. 2002; 17 (Available at:): S45-S46
      1. International Organization for Standardization. ISO 23500-5_2019. Preparation and quality management of fluids for haemodialysis and related therapies—part 5: quality of dialysis fluid for haemodialysis and related therapies. Available at: https://www.iso.org/standard/67614.html. Accessed July 1, 2019.

        • National Kidney Foundation report on dialyzer reuse
        Task Force on Reuse of Dialyzers, Council on Dialysis, National Kidney Foundation.
        Am J Kidney Dis. 1997; 30: 859-871
        • Dhrolia M.F.
        • Imtiaz S.
        • Qureshi R.
        • et al.
        Reusing dialyzer in low income countries: a good cost saving tactic with complex ethics.
        J Pak Med Assoc. 2017; 67: 1254-1257
        • Ibeas J.
        • Roca-Tey R.
        • Vallespin J.
        • et al.
        Spanish clinical guidelines on vascular access for haemodialysis.
        Nefrologia. 2017; 37: 1-191
        • Lowrie E.G.
        • Laird N.M.
        • Parker T.F.
        • et al.
        Effect of the hemodialysis prescription on patient morbidity: report from the National Cooperative Dialysis Study.
        N Engl J Med. 1981; 305: 1176-1181
        • Gotch F.A.
        • Sargent J.A.
        A mechanistic analysis of the National Cooperative Dialysis Study (NCDS).
        Kidney Int. 2018; 28: 526-534
        • Cheung A.K.
        • Levin N.W.
        • Greene T.
        • et al.
        Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study.
        J Am Soc Nephrol. 2003; 14: 3251-3263
        • Tong A.
        • Manns B.
        • Wang A.Y.M.
        • et al.
        • for the SONG Implementation Workshop Investigators
        Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop.
        Kidney Int. 2018; 18: 30603
        • Perl J.
        • Dember L.M.
        • Bargman J.M.
        • et al.
        • on behalf of the American Society of Nephrology Dialysis Advisory Group
        The use of a multidimensional measure of dialysis adequacy—moving beyond small solute kinetics.
        Clin J Am Soc Nephrol. 2017; 12: 839-847
        • Obi Y.
        • Streja E.
        • Rhee C.M.
        • et al.
        Incremental hemodialysis, residual kidney function, and mortality risk in incident dialysis patients: a cohort study.
        Am J Kidney Dis. 2016; 68: 256-265
        • Chin A.I.
        • Appasamy S.
        • Carey R.J.
        • et al.
        Feasibility of incremental 2-times weekly hemodialysis in incident patients with residual kidney function.
        Kidney Int Rep. 2017; 2: 933-942
        • Kalantar-Zadeh K.
        • Unruh M.
        • Zager P.G.
        • et al.
        Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy.
        Am J Kidney Dis. 2014; 64: 181-186
        • Nakao T.
        • Toshimasa Y.
        • Takahashi T.
        Once-weekly hemodialysis combined with low-protein and low-salt dietary treatment as a favorable therapeutic modality for selected patients with end-stage renal failure: a prospective observational study in Japanese patients.
        BMC Nephrol. 2018; 19: 151
        • Flythe J.E.
        • Kimmel S.E.
        • Brunelli S.M.
        Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality.
        Kidney Int. 2011; 79: 250-257
        • K/DOQI Workgroup
        K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.
        Am J Kidney Dis. 2015; 45: S1-S153
        • Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group
        KDIGO Clinical Practice Guideline for the management of blood pressure in chronic kidney disease.
        Kidney Int Suppl. 2012; 2: 337-414
        • Agarwal R.
        • Flynn J.
        • Pogue V.
        • et al.
        Weir assessment and management of hypertension in patients on dialysis.
        J Am Soc Nephrol. 2014; 25: 1630-1646
        • McIntyre C.W.
        • Goldsmith D.J.
        Ischemic brain injury in hemodialysis patients: which is more dangerous, hypertension or intradialytic hypotension?.
        Kidney Int. 2015; 87: 1109-1115
        • Jefferies H.J.
        • Crowley L.E.
        • Harrison L.E.
        • et al.
        Circulating endotoxemia and frequent hemodialysis schedules.
        Nephron Clin Pract. 2014; 128: 141-146
        • Mazzuchi N.
        • Carbonell E.
        • Fernández-Cean J.
        Importance of blood pressure control in hemodialysis patient survival.
        Kidney Int. 2000; 58: 2147-2154
        • Odudu A.
        • McIntyre C.W.
        An update on intradialytic cardiac dysfunction.
        Semin Dial. 2016; 29: 435-441
        • Assimon M.M.
        • Wenger J.B.
        • Wang L.
        • et al.
        Ultrafiltration rate and mortality in maintenance hemodialysis patients.
        Am J Kidney Dis. 2016; 68: 911-922
        • Rosner M.H.
        • Ronco C.
        Techniques for the assessment of volume status in patients with end stage renal disease.
        Semin Dial. 2014; 27: 538-541
        • Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group
        KDIGO Clinical Practice Guideline for anemia in chronic kidney disease.
        Kidney Int Suppl. 2012; 2: 279-335
        • Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group
        KDIGO 2017 Clinical Practice Guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD).
        Kidney Int Suppl. 2017; 7: 1-59
        • Palmer S.C.
        • Navaneethan S.D.
        • Craig J.C.
        • et al.
        Erythropoiesis-stimulating agents in people with chronic kidney disease: systematic review and meta-analysis.
        Ann Intern Med. 2010; 153: 23-33
        • Patel L.
        • Bernard L.M.
        • Elder G.J.
        Sevelamer versus calcium-based binders for treatment of hyperphosphatemia in CKD: a meta-analysis of randomized controlled trials.
        Clin J Am Soc Nephrol. 2016; 11: 232-244
        • Palmer S.C.
        • Gardner S.
        • Craig J.C.
        • et al.
        Phosphate binding agents in adults with chronic kidney disease: a network meta-analysis.
        Am J Kidney Dis. 2016; 68: 691-702
        • Harel Z.
        • Silver S.A.
        • McQuillan R.F.
        • et al.
        How to diagnose solutions to a quality of care problem.
        Clin J Am Soc Nephrol. 2016; 11: 901-907
        • Unruh M.
        • Williams M.
        Patient-centered quality of care in dialysis: an introduction.
        Semin Dial. 2016; 29: 91-92
        • Mapes D.L.
        • Lopes A.A.
        • Satayathum S.
        • et al.
        Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
        Kidney Int. 2003; 64: 339-349
        • Weisbord S.D.
        • Fried L.F.
        • Mor M.K.
        • et al.
        Renal provider recognition of symptoms in patients on maintenance hemodialysis.
        Clin J Am Soc Nephrol. 2007; 2: 960-967
        • Finkelstein F.O.
        • Finkelstein S.H.
        Time to rethink our approach to patient-reported outcome measures for ESRD.
        Clin J Am Soc Nephrol. 2017; 12: 1885-1888
        • Kliger A.S.
        Quality measures for dialysis: time for a balanced scorecard.
        Clin J Am Soc Nephrol. 2016; 11: 363-368
        • Garg A.X.
        • Suri S.
        • Eggers P.
        • et al.
        Patients receiving frequent hemodialysis have better health related quality of life compared to patients receiving conventional hemodialysis.
        Kidney Int. 2017; 91: 746-754
        • Kraus M.A.
        • Fluck R.J.
        • Weinhandl E.D.
        • et al.
        Intensive hemodialysis and health-related quality of life.
        Am J Kidney Dis. 2016; 68: S33-S42
        • Suwabe T.
        • Barrera-Flores F.J.
        • Rodriguez-Gutierrez R.
        • et al.
        Effect of online hemodiafiltration compared with hemodialysis on quality of life in patients with ESRD: a systematic review and meta-analysis of randomized trials.
        PLoS One. 2018; 13e0205037
        • Mazairac A.H.
        • de Wit G.A.
        • Grooteman M.P.
        • et al.
        Clinical performance targets and quality of life in hemodialysis patients.
        Blood Purif. 2012; 33: 73-79
        • Saad M.M.
        • El Douaihy Y.
        • Boumitri C.
        • et al.
        Predictors of quality of life in patients with end-stage renal disease on hemodialysis.
        Int J Nephrol Renovasc Dis. 2015; 8: 119-123
        • Delgado C.
        • Shieh S.
        • Brimes B.
        • et al.
        Association of self-reported frailty with falls and fractures among patients new to dialysis.
        Am J Nephrol. 2015; 42: 134-140
        • Cook W.L.
        • Tomlinson G.
        • Donaldson M.
        • et al.
        Falls and fall-related injuries in older dialysis patients.
        Clin J Am Soc Nephrol. 2006; 1: 1197-1204
        • Gilbertson E.L.
        • Krishnasamy R.
        • Foote C.
        • et al.
        Burden of care and quality of life among caregivers for adults receiving maintenance dialysis: a systematic review.
        Am J Kidney Dis. 2019; 73: 332-343
        • Mehrotra R.
        • Devuyst O.
        • Davies S.J.
        • et al.
        The current state of peritoneal dialysis.
        J Am Soc Nephrol. 2016; 27: 3238-3252
        • Karopadi A.N.
        • Mason G.
        • Rettore E.
        • et al.
        The role of economies of scale in the cost of dialysis across the world: a macroeconomic perspective.
        Nephrol Dial Transplant. 2014; 29: 885-892
        • Wang V.
        • Maciejewski M.L.
        • Coffman C.J.
        • et al.
        Impacts of geographic distance on peritoneal dialysis utilization: refining models of treatment selection.
        Health Serv Res. 2017; 52: 35-55
        • Li P.K.
        • Chow K.M.
        • Van de Luijtgaarden M.W.
        • et al.
        Changes in the worldwide epidemiology of peritoneal dialysis.
        Nat Rev Nephrol. 2017; 13: 90-103
        • Palmer D.
        • Lawton W.J.
        • Barrier Jr., C.
        • et al.
        Peritoneal dialysis for AKI in Cameroon: commercial vs locally-made solutions.
        Perit Dial Int. 2018; 38: 246-250
        • Afolalu B.
        • Troidle L.
        • Osayimwen O.
        • et al.
        Technique failure and center size technique failure and center size in a large cohort of PD patients in a defined geographic area.
        Perit Dial Int. 2009; 29: 292-296
        • Chuengsaman P.
        • Kasemsup V.
        PD first policy: Thailand's response to the challenge of meeting the needs of patients with end-stage renal disease.
        Semin Nephrol. 2017; 37: 287-295
        • United States Renal Data System
        2018 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States.
        National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD2019
        • Figueiredo A.E.
        • Bernardini J.
        • Bowes E.
        • et al.
        A syllabus for teaching peritoneal dialysis to patients and caregivers.
        Perit Dial Int. 2016; 36: 592-605
        • Crabtree J.
        • Chow K.M.
        Peritoneal dialysis catheter insertion.
        Semin Nephrol. 2017; 37: 17-29
        • Lo W.K.
        • Bargman J.M.
        • Burkart J.
        • et al.
        Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis.
        Perit Dial Int. 2006; 26: 520-522
        • Wetmore J.B.
        • Peng Y.
        • Monda K.L.
        • et al.
        Trends in anemia management practices in patients receiving hemodialysis and peritoneal dialysis: a retrospective cohort analysis.
        Am J Nephrol. 2015; 41: 354-361
        • Nataatmadja M.
        • Cho Y.
        • Johnson D.W.
        Continuous quality improvement initiatives to sustainably reduce peritoneal dialysis-related infections in Australia and New Zealand.
        Perit Dial Int. 2016; 36: 472-477
        • Troidle L.
        • Watnick S.
        • Wuerth D.B.
        • et al.
        Depression and its association with peritonitis in long-term peritoneal dialysis patients.
        Am J Kidney Dis. 2003; 42: 350-354
        • Wuerth D.
        • Finkelstein S.H.
        • Finkelstein F.O.
        Psychosocial assessment of the patient on chronic peritoneal dialysis: an overview.
        Adv Chronic Kidney Dis. 2007; 14: 353-357
        • Harris D.C.H.
        • Davies S.J.
        • Finkelstein F.O.
        • et al.
        Increasing access to integrated ESKD care as part of universal health coverage.
        Kidney Int. 2019; 95: S1-S33

      Linked Article

      • Dialysis funding, eligibility, procurement, and protocols in low- and middle-income settings: results from the International Society of Nephrology collection survey
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          Dialysis provisions and end-stage kidney disease (ESKD) care represents an important challenge, particularly in low-resource settings. The purpose of this project was to survey nephrologists from low- and lower middle-income countries about their experiences in the following domains: (i) Dialysis funding and eligibility; (ii) dialysis-procurement mechanisms; (iii) clinical protocols for dialysis; (iv) monitoring of dialysis outcomes; and (v) barriers to care for ESKD. One hundred and twenty responses from 31 low- and middle-income countries, from 8 ISN regions, were included in the analysis.
        • Full-Text
        • PDF
      • The role of kidney transplantation as a component of integrated care for chronic kidney disease
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          Kidney transplant provides superior outcomes to dialysis as a treatment for end-stage kidney disease. Therefore, it is essential that kidney transplantation be part of an integrated treatment and management plan for chronic kidney disease (CKD). Developing an effective national program of transplantation is challenging because of the requirement for kidney donors and the need for a multidisciplinary team to provide expert care for both donors and recipients. This article outlines the steps necessary to establish a national kidney transplant program, starting with the requirement for effective legislation that provides the legal framework for transplantation whilst protecting organ donors, their families, recipients, and staff and is an essential requirement to combat organ trafficking.
        • Full-Text
        • PDF
      • Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          A large gap between the number of people with end-stage kidney disease (ESKD) who received kidney replacement therapy (KRT) and those who needed it has been recently identified, and it is estimated that approximately one-half to three-quarters of all people with ESKD in the world may have died prematurely because they could not receive KRT. This estimate is aligned with a previous report that estimated that >3 million people in the world died each year because they could not access KRT. This review discusses the reasons for the differences in treated and untreated ESKD and KRT modalities and outcomes and presents strategies to close the global KRT gap by establishing robust health information systems to guide resource allocation to areas of need, inform KRT service planning, enable policy development, and monitor KRT health outcomes.
        • Full-Text
        • PDF
      • Considerations on equity in management of end-stage kidney disease in low- and middle-income countries
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          Achievement of equity in health requires development of a health system in which everyone has a fair opportunity to attain their full health potential. The current, large country-level variation in the reported incidence and prevalence of treated end-stage kidney disease indicates the existence of system-level inequities. Equitable implementation of kidney replacement therapy (KRT) programs must address issues of availability, affordability, and acceptability. The major structural factors that impact equity in KRT in different countries are the organization of health systems, overall health care spending, funding and delivery models, and nature of KRT prioritization (transplantation, hemodialysis or peritoneal dialysis, and conservative care).
        • Full-Text
        • PDF
      • Global case studies for chronic kidney disease/end-stage kidney disease care
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          The prevalence of chronic kidney disease and its risk factors is increasing worldwide, and the rapid rise in global need for end-stage kidney disease care is a major challenge for health systems, particularly in low- and middle-income countries. Countries are responding to the challenge of end-stage kidney disease in different ways, with variable provision of the components of a kidney care strategy, including effective prevention, detection, conservative care, kidney transplantation, and an appropriate mix of dialysis modalities.
        • Full-Text
        • PDF
      • Framework for establishing integrated kidney care programs in low- and middle-income countries
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          Secular increases in the burden of kidney failure is a major challenge for health systems worldwide, especially in low- and middle-income countries (LMICs) due to growing demand for expensive kidney replacement therapies. In LMICs with limited resources, the priority of providing kidney replacement therapies must be weighed against the prevention and treatment of chronic kidney disease, other kidney disorders such as acute kidney injury, and other noncommunicable diseases, as well as other urgent public health needs.
        • Full-Text
        • PDF
      • Supportive care for end-stage kidney disease: an integral part of kidney services across a range of income settings around the world
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          A key component of treatment for all people with advanced kidney disease is supportive care, which aims to improve quality of life and can be provided alongside therapies intended to prolong life, such as dialysis. This article addresses the key considerations of supportive care as part of integrated end-stage kidney disease care, with particular attention paid to programs in low- and middle-income countries. Supportive care should be an integrated component of care for patients with advanced chronic kidney disease, patients receiving kidney replacement therapy (KRT), and patients receiving non-KRT conservative care.
        • Full-Text
        • PDF
      • Developing the ethical framework of end-stage kidney disease care: from practice to policy
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          Ethical issues relating to end-stage kidney disease (ESKD) care are increasingly being discussed by clinicians and ethicists but are still infrequently considered at a policy level or in the education and training of health care professionals. In most lower-income countries, access to kidney replacement therapies such as dialysis is not universal, leading to overt or implicit rationing of resources and potential exclusion from care of those who are unable to sustain out-of-pocket payments. These circumstances create significant inequities in access to ESKD care within and between countries and impose emotional and moral burdens on patients, families, and health care workers involved in decision-making and provision of care.
        • Full-Text
        • PDF
      • Challenges for sustainable end-stage kidney disease care in low-middle-income countries: the problem of the workforce
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          Prevention and early detection of kidney diseases in adults and children should be a priority for any government health department. This is particularly pertinent in the low-middle-income countries, mostly in Asia, Africa, Latin America, and the Caribbean, where up to 7 million people die because of lack of end-stage kidney disease treatment. The nephrology workforce (nurses, technicians, and doctors) is limited in these countries and expanding the size and expertise of the workforce is essential to permit expansion of treatment for both chronic kidney disease and end-stage kidney disease.
        • Full-Text
        • PDF
      • The second Global Kidney Health Summit outputs: developing a strategic plan to increase access to integrated end-stage kidney disease care worldwide
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          The articles in this edition of Kidney International Supplements describe the background, rationale, and action plans for developing a strategic approach to increase access to integrated end-stage kidney disease (ESKD) care worldwide over the next decade. It is estimated that the number of people dying globally with ESKD for want of kidney replacement therapy is up to 3 times the number who receive it.1 Kidney transplantation meets only a small fraction of this therapeutic need. Many patients with advanced kidney disease, whether receiving kidney replacement therapy or not, suffer considerably because they have no access to supportive care.
        • Full-Text
        • PDF